Eugene

[email protected]

LATEST

Novo Nordisk To Invest $22 Million in US Finished-Products Mfg Plant
By

By
Following an announced $65-million investment in February (2018), Novo Nordisk plans to invest an additional $22 million in its finished-products manufacturing plant in Clayton, Johnston County, North Carolina. This is…

Takeda and Shire Shareholders Approve $62-Billion Proposed Acquisition of Shire
By

By
Following December 5th shareholder meetings, Takeda Pharmaceutical and Shire announced that their respective shareholders have voted in favor of Takeda’s pending $62-billion acquisition of Shire. The deal is now subject…

GSK To Sell Select Consumer Healthcare Nutrition Products to Unilever in $3.9-Billion Deal
By

By
Following a previously announced strategic review, GlaxoSmithKline (GSK) has agreed to sell the Horlicks brand, its malted milk drink, and its other consumer healthcare nutrition brands to Unilever, a London,…

GSK To Acquire Oncology-Focused Biopharm Company Tesaro for $5.1 Billion
By

By
GlaxoSmithKline (GSK) plans to acquire Tesaro, a Waltham, Massachusetts-based oncology-focused biopharmaceutical company, for approximately $5.1 billion to accelerate the build of GSK’s pipeline and commercial capability in oncology. Tesaro is…

FDA OKs Teva’s, Celltrion’s Biosimilar of Roche’s Rituxan
By

By
The US Food and Drug Administration (FDA) has approved Truxima (rituximab-abbs), a biosimilar of Roche’s Rituxan (rituximab), a drug to treat certain cancers and autoimmune diseases, from Teva Pharmaceutical Industries…

Bayer Plans Job Reductions of 12,000
By

By
Bayer has announced staff reductions of approximately 10% of its global workforce, or 12,000 employees, across all of its business by the end of 2021. Approximately half of these cuts…

FDA Approval of Second Drug Based on Biomarker Leads New Molecular Entity Drug Approvals
By

By
The FDA has approved a second cancer treatment based on a biomarker, rather than tumor location. Plus, a roundup of approvals of new molecular entities by the FDA from November…

Lonza, WuXi Biologics, Catalent, and More Expand; CordenPharma Completes Audit
By

By
A roundup of the latest news from suppliers, contract development and manufacturing organizations and contract manufacturing organizations, featuring Lonza, CordenPharma, Catalent Pharma Solutions, WuXi Biologics, PCI Pharma Services, and Kingchem…

Mylan, Teva Initiate US Recall of Valsartan Products
By

By
Mylan and Teva Pharmaceutical Industries have issued a voluntary recall to the consumer level of select lots of valsartan-containing products due to detected trace amounts of an impurity, N-nitrosodiethylamine (NDEA)…

FDA Issues Warning Letter to Mylan for Finished Pharmaceuticals Mfg Plant
By

By
The US Food and Drug Administration (FDA) has issued a Warning Letter to Mylan for its manufacturing plant in Morgantown, West Virginia for cGMP violations for finished pharmaceuticals following an…